Skip to main content

ESTUDIO DE LA FUNCION DE PLA2G4E EN PLASTICIDAD CEREBRAL Y EN LA RESILIENCIA COGNITIVA. NUEVA ESTRATEGIA PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER

PID2019-104921RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION MEDICA APLICADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice

  • Badesso, Sara
  • Perez-Gonzalez, Marta
  • Exposito, Sara
  • Espelosin, Maria
  • Cambria, Clara
  • D'Andrea, Laura
  • Imperato, Gabriele
  • Moeini, Pedram
  • Vales, Africa
  • Gonzalez-Aseguinolaza, Gloria
  • Mitro, Nico
  • Antonucci, Flavia
  • Martín, Eduardo D
  • Marcello, Elena
  • Cuadrado-Tejedor, Mar
  • Garcia-Osta, Ana
Given its potential role in supporting cognitive resilience, PLA2G4E has emerged as a compelling therapeutic target in the context of Alzheimer's disease (AD). However, its physiological functions in the central nervous system remain largely unexplored. In this study, we demonstrate that Pla2g4e expression peaks during early postnatal brain development, coinciding with the rapid formation of synapses. Loss-of-function experiments in primary neuronal cultures revealed that Pla2g4e expression is essential for proper dendritic development and neuronal maturation. In constitutive Pla2g4e knockout mice, we observed significant disruptions in the developmental profiles of cortical synaptic plasticity markers, accompanied by impairments in memory-related behaviors. Notably, the adeno-associated virus-mediated overexpression of PLA2G4E rescued memory deficits, highlighting its functional relevance in cognitive processes. Furthermore, selective deletion of Pla2g4e in excitatory neurons of the adult brain resulted in moderate memory impairments in aged animals, suggesting an ongoing role in synaptic maintenance. Together, these findings establish PLA2G4E as a key regulator of dendritic architecture, synaptic function, and cognitive performance, and highlight its potential as a gene therapy target for neurodegenerative diseases characterized by synaptic dysfunction., This work was supported by PID2022-138285OB-I00, financiado por MCIN/AEI/10.13039/501100011033/FEDER, UE, and PID2019-104921RB-I00 financiado por MCIN/AEI/10.13039/501100011033 to A Garcia-Osta and M Cuadrado-Tejedor; CaixaImpulse: CI20_00207 to A Garcia-Osta; the GMP and Adey Foundations, Asociación de Amigos, and FENS-IBRO-PERC exchange fellowship grants to S Badesso; and grant PID2020-116327GB-I00 to ED Martín. This work was also supported partially by the Ministry of University and Research (MUR) Progetto Eccellenza (2022–2027) to the Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti,” Università degli Studi di Milano, and partially by the Italian Ministry of Health with Ricerca Corrente and “5xmille” funds to N Mitro. F Antonucci is economically supported by Italian Ministry of Research—PRIN: PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE—No. 20229XWM5L; Telethon Foundation—Seed Grant Spring 2022 RETT—Project N. 419; and Associazione Nazionale Atassia Telangiectasia (ANAT)—ANAT Research Grants 2022. This project has received funding from the Italian Ministry of University and Research (PRIN202039WMFP and PRIN2022 PNRR P2022R2E8N to E Marcello), from the Giovanni Armenise Harvard Foundation and AIRALZH ONLUS (2023 Armenise Harvard-AIRALZH Mid-Career Award in Neurodegenerative Diseases—AHA-MCA to E Marcello), and from the Italian Ministry of Enterprises and Made in Italy (PNRR—Next generation EU funding, “SEED for Innovation Patent 2.0” program, project TT_MIN23_SEED4IP2.0_07 to E Marcello)., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Docosahexaenoic acid ameliorates contextual fear memory deficits in the Tg2576 Alzheimer´s disease mouse model: cellular and molecular correlates

  • Badesso, Sara
  • Cartas Cejudo, Paz
  • Espelosín, María
  • Santamaría Martínez, Enrique
  • Cuadrado-Tejedor, Mar
  • García-Osta, Ana
Docosahexaenoic acid (DHA), the most abundant polyunsaturated fatty acid in the brain, is essential for successful aging. In fact, epidemiological studies have demonstrated that increased intake of DHA might lower the risk for developing Alzheimer’s disease (AD). These observations are supported by studies in animal models showing that DHA reduces synaptic pathology and memory deficits. Different mechanisms to explain these beneficial effects have been proposed; however, the molecular pathways involved are still unknown. In this study, to unravel the main underlying molecular mechanisms activated upon DHA treatment, the effect of a high dose of DHA on cognitive function and AD pathology was analyzed in aged Tg2576 mice and their wild-type littermates. Transcriptomic analysis of mice hippocampi using RNA sequencing was subsequently performed. Our results revealed that, through an amyloid-independent mechanism, DHA enhanced memory function and increased synapse formation only in the Tg2576 mice. Likewise, the IPA analysis demonstrated that essential neuronal functions related to synaptogenesis, neuritogenesis, the branching of neurites, the density of dendritic spines and the outgrowth of axons were upregulated upon-DHA treatment in Tg2576 mice. Our results suggest that memory function in APP mice is influenced by DHA intake; therefore, a high dose of daily DHA should be tested as a dietary supplement for AD dementia prevention., Grant funding support from the Ministry of Science and Innovation (MINECO) with exp. PID2019-104921RB-I00/MCI/AEI/10.13039/501100011033. Foundation for Applied Medical Research, the University of Navarra (Pamplona, Spain) for financial support and the Asociación de Amigos of the University of Navarra for the grant to S.B.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Amyloid-driven tau accumulation on mitochondria potentially leads to cognitive deterioration in Alzheimer’s disease

  • Cuadrado-Tejedor, Mar
  • Pérez-González, Marta
  • Alfaro-Ruiz, Rocío
  • Badesso, Sara
  • Sucunza, Diego
  • Espelosín, María
  • Ursúa, Susana
  • Lachén Montes, Mercedes
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • Luján, Rafael
  • García-Osta, Ana
Despite the well-accepted role of the two main neuropathological markers (β-amyloid and tau) in the progression of Alzheimer’s disease, the interaction and specific contribution of each of them is not fully elucidated. To address this question, in the present study, an adeno-associated virus (AAV9) carrying the mutant P301L form of human tau, was injected into the dorsal hippocampi of APP/PS1 transgenic mice or wild type mice (WT). Three months after injections, memory tasks, biochemical and immunohistochemical analysis were performed. We found that the overexpression of hTauP301L accelerates memory deficits in APP/PS1 mice, but it did not affect memory function of WT mice. Likewise, biochemical assays showed that only in the case of APP/PS1-hTauP301L injected mice, an important accumulation of tau was observed in the insoluble urea fraction. Similarly, electron microscopy images revealed that numerous clusters of tau immunoparticles appear at the dendrites of APP/PS1 injected mice and not in WT animals, suggesting that the presence of amyloid is necessary to induce tau aggregation. Interestingly, these tau immunoparticles accumulate in dendritic mitochondria in the APP/PS1 mice, whereas most of mitochondria in WT injected mice remain free of tau immunoparticles. Taken together, it seems that amyloid induces tau aggregation and accumulation in the dendritic mitochondria and subsequently may alter synapse function, thus, contributing to accelerate cognitive decline in APP/PS1 mice., ) to J.F.-I. and E.S and from the Department of Economic and Business Development from Government of Navarra (INNOLFACT project; Ref. 0011-1411-2020-000028).We gratefully acknowledge grant funding support from Ministry of Science and Innovation (MINECO) with exp. PID2019-104921RB-I00/MCI/AEI/10.13039/501100011033as well as to the Foundation for Applied Medical Research, the University of Navarra (Pamplona, Spain) for financial support and the Asociación de Amigos of the University of Navarra for the grant to M.P.-G. and S.B. We also gratefully acknowledge grant funding support from Spanish Ministerio de Economía y Competitividad (RTI2018-095812-B-I00 MCIN/ AEI/10.13039/501100011033) y por FEDER una manera de hacer Europa and Junta de Comunidades de Castilla-La Mancha (SBPLY/17/180501/000229) to RL, from the Spanish Ministry of Science Innovation and Universities (Ref. PID2019-110356RB-I00/AEI/10.13039/501100011033
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Improvement of cognitive function in wild-type and Alzheimer's disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells

  • Casares, Noelia
  • Alfaro Larraya, María
  • Cuadrado-Tejedor, Mar
  • Lasarte-Cía, Aritz
  • Navarro Negredo, Flor
  • Vivas, Isabel
  • Espelosín, María
  • Cartas Cejudo, Paz
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • García-Osta, Ana
  • Lasarte, Juan José
A complex network of interactions exists between the olfactory, immune and central nervous systems. In this work we intend to investigate this connection through the use of an immunostimulatory odorant like menthol, analyzing its impact on the immune system and the cognitive capacity in healthy and Alzheimer’s Disease Mouse Models. We first found that repeated short exposures to menthol odor enhanced the immune response against ovalbumin immunization. Menthol inhalation also improved the cognitive capacity of immunocompetent mice but not in immunodeficient NSG mice, which exhibited very poor fear-conditioning. This improvement was associated with a downregulation of IL-1β and IL-6 mRNA in the brain´s prefrontal cortex, and it was impaired by anosmia induction with methimazole. Exposure to menthol for 6 months (1 week per month) prevented the cognitive impairment observed in the APP/PS1 mouse model of Alzheimer. Besides, this improvement was also observed by the depletion or inhibition of T regulatory cells. Treg depletion also improved the cognitive capacity of the APPNL-G-F/NL-G-F Alzheimer´s mouse model. In all cases, the improvement in learning capacity was associated with a downregulation of IL-1β mRNA. Blockade of the IL-1 receptor with anakinra resulted in a significant increase in cognitive capacity in healthy mice as well as in the APP/PS1 model of Alzheimer´s disease. These data suggest an association between the immunomodulatory capacity of smells and their impact on the cognitive functions of the animals, highlighting the potential of odors and immune modulators as therapeutic agents for CNS-related diseases., This work was supported by a grant from the Ministry of Science and Innovation (PID2021-128283OA-I00 financed by MCIN/ AEI /10.13039/501100011033 and by FEDER A way of making Europe and PID2019-104921RB-I00), Department of Economic and Business Development from the Government of Navarra (INNOLFACT project; Ref. 0011-1411-2020-000028) and Explora grant from Ministry of Economy and Competitiveness, (SAF2013-50067-EXP to JL).